Mammography Market Size, Share, Growth | Report 2022-2030

According to Vision Research Reports, the mammography market size is expected to be worth around US$ 13.8 billion by 2030 from valued at US$ 11.43 billion in 2020 and poised to grow at a CAGR of 21.5% from 2021 to 2030.

Growth Factors

 The market growth can be attributed to the rising initiatives by various governments and NGOs to raise awareness about early diagnosis of micro calcifications in breast tissue. Some significant organizations such as the National Breast Cancer Foundation, CDC, and Breast Cancer Organization are promoting the early diagnosis of mammary gland calcification, which is one of the crucial factors expected to drive the demand over the forecast period.

Full Report is Ready | Get the sample copy of report@

Based on a report published by the National Cancer Institute in 2020, it was stated that the proportion of women aged 45 to 65 years had increased to 81.1% in breast cancer screening. Major mammography manufacturers are introducing new products and increasing the number of approved products, which is further expected to impel the demand in the coming years.

Report Coverage


Market Size

US$ 13.8 billion by 2030

Growth Rate

CAGR of 21.5% From 2021 to 2030

Base Year


Historic Data

2017 to 2020

Forecast Period

2021 to 2030

Segments Covered

Product, Technology

Regional Scope

North America, Latin America, Europe, Asia Pacific, MEA

Companies Mentioned

Hologic; Fujifilm; Siemens Healthcare; Phillips Healthcare; Toshiba Medical Systems, GE Healthcare; Metaltronica; I.M.S. Srl


The COVID-19 pandemic has been continuing to transform the growth of various markets, and the immediate impact of the outbreak is varied. Initially, the COVID-19 outbreak showed a strong impact on the mammography market as many hospitals and screening centers remain closed due to lockdowns, and the demand for mammography procedures is expected to be subdued in the short term. For Instance, According to an article appearing in the JAMA Network in August 2020, titled "HER2-Targeted Therapies Introduced Early in Breast Cancer Treatment Offering Hope for Patients" there has been a significant decline in breast cancer diagnoses (by as much as 51.8%) in the United States from March 1, 2020, to April 18, 2020. Thus, this is expected to have a significant impact on mammography device manufacturers, as their demand has reduced significantly.

Moreover, the major factors responsible for the growth of the mammography market include the growing prevalence of breast cancer, technological advancements in breast imaging, and investment from various organizations in breast cancer screening campaigns. According to a Globocan report in 2020, breast cancer was the most prevalent type of cancer, with a prevalence rate of 11.7%. According to the same report, the five-year prevalence rate for both the sexes showed that Asia had the highest number of people affected at 3,218,496 (41.3%), followed by Europe at 2,138,117 (27.4%) and North America with 1.189,111 people (15.3%). Such high prevalence rates of breast cancer are one of the main reasons the demand for mammography devices is expected to increase, as they may be used for diagnostic purposes.

Furthermore, as per the data published by United , in October 2021, the total number of mammography procedures performed across the United States was around 38,698,995. Therefore, the increasing number of mammography tests performed is likely to have a positive impact on the growth of the market in countries, like the United States. Hence, the aforesaid factors help in driving the growth of the market studied. Many major tech companies are using AI (artificial intelligence) models that can automatically detect breast cancer. For instance, in June 2020, Vara, a Berlin-based company raised EUR 6.5 million in Series A funding for AI-powered breast cancer screening software. These programs and technological advancements associated with mammograms are expected to boost market growth.​ Additionally, In June 2019, Fujifilm Medical Systems USA initiated a new breast cancer screening awareness campaign, focused on early detection of the disease in the United States. The ‘Aspire to Be Fearless’ campaign involves a mobile mammography vehicle that will be traveling throughout the country to spread Fujifilm’s message. The vehicle includes a waiting room, dressing room, and the latest breast imaging solutions from Fujifilm.

Also, in November 2020, Hologic Inc. and RadNet entered into collaboration to advance the development of artificial intelligence tools in breast health. The collaboration may include data sharing, R&D, and an upgrade of RadNet’s fleet of Hologic mammography systems to state-of-the-art imaging technology. Furthermore, in September 2020, GE Healthcare and Candelis Inc. entered into a collaboration to enhance mammography workflow, image management, and storage capabilities for the Senographe Pristina Mammography System. Thus, the above-mentioned factors, coupled with the changing market needs, are expected to drive market growth.​

The Digital Mammography Segment is Expected to Account for the Large Market Share During the Forecast Period

As breast cancer patients are at higher risk of acquiring the infection, many organizations took definite measures to manage these diseases. According to a research article by Dafina Petrova et al., published in Medicina Clínica Journal in September 2020, the European Society for Medical Oncology (ESMO), the Spanish Society of Radiation Oncology (SEOR), and the Spanish Society of Medical Oncology (SEOM) have published some recommendations on how to modify treatment protocols to minimize risks in cancer patients. The improved guidelines would provide more efficient methods to perform surgeries which would have a positive impact on the treatments. Such instances are expected to support the growth of the digital mammography market. With the advent of digital mammography, an increasing number of countries are experiencing shifts toward these newer systems, due to their superior depiction of low-contrast objects, wider dynamic change, and improved diagnostic quality of images, especially when examining denser breasts. 

Product launches are another factor for segmental growth. For instance, in August 2021, FUJIFILM Medical Systems U.S.A., Inc. launched ScreenPoint Medical’s, FDA cleared Transpara powered by Fusion AI for 2D and 3D mammography in the United States. Additionally, In April 2021, Fujifilm Europe GmbH launched the “Harmony” version of its Amulet Innovality mammography system in Germany. AMULET Innovality is a Full Field Digital Mammography (FFDM) equipped with Fujifilm’s unique and innovative technologies that achieve optimum image quality at a very low patient dose. Thus, digital mammography is becoming the preferred choice of screening, even though the cost of the new technology is six times higher than the conventional systems. 

Radiation exposure is significantly lower as compared to analog systems. All these advantages aid in the growth of the market over the forecast period. Moreover, as per the American Cancer Society, in 2019, there were around 8,130 Ductal carcinomas in situ (DCIS) and 37,150 invasive breast cancer new cases among females aged between 40 to 49 years reported in the United States. Thus, the rising prevalence of breast cancer is likely to boost the demand for digital mammography.

Full Report is Ready | Buy this Premium Research Report@

North America Accounts for the Large Share in the Global Market Over the Forecast Period

North America is found to hold a major share of the mammography market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. The rising prevalence of breast cancer and the presence of better healthcare infrastructure in the region are expected to drive the overall growth of the market over the forecast period. 

Due to the outbreak of COVID-19, the market is expected to face a slight setback owing to the delay in diagnosis, drug shortages, and others. However, as lockdowns and restrictions are getting relaxed, there may be an increase in demand for mammography services. Many women who had canceled their appointments or had their visits for mammography services postponed are now able to get their tests done. The Breast Cancer Research Foundation in the United States has stated that hospitals and facilities in most places are well prepared and safe now as compared to the initial days of the COVID-19 pandemic. Thus, it has been encouraging women to get their scheduled scans done so that diagnosis is not delayed. 

According to the American Cancer Society, in 2020, an estimated 276,480 new cases of invasive breast cancer have been diagnosed among women. Additionally, 48,530 cases of in situ breast carcinoma have been diagnosed among women, and the number of breast cancer cases is expected to increase in the coming years. 

Furthermore, several companies are found launching programs to support breast cancer tests. For example, in August 2020, Hologic Inc. reported the Back to Screening campaign launch, which may encourage women to schedule their delayed mammograms due to the COVID-19 pandemic. 

The growth is also being fueled by the launch and growing adoption of advanced mammography devices with innovative technologies. For instance, in October 2021, FUJIFILM Canada Inc. received a Health Canada medical device license for its ASPIRE Cristalle digital mammography solution. It also expanded its partnership with Christie Innomed to offer the product across every province in Canada.​

Thus, owing to the rising prevalence of breast cancer and product launches, the market is expected to experience growth over the forecast period.

Report Highlights

Digital systems segment held the 62.1% of the revenue share in 2020. The growing demand for technologically advanced breast cancer screening and diagnostic equipment is one of the crucial factors expected to drive the market in the coming years. The presence of favorable reimbursement policies and growing government support in improving screening results are some of the key attributes that account for the largest revenue share of the global mammography market.

However, 3D mammography system market is the fastest growing product segment with a CAGR of 13.1% during 2016 to 2025. The presence of the Modernization Act, 2020, is one of the pivotal factors up surging the demand for 3D systems in the coming years. The rising demand for highly specific screening equipment to reduce call-back visits, false alarm, and missed cancer diagnosis is also one of the main factors contributing to the up surging demand.

Digital mammography technology held approximately 69.3% share in 2020. Rapidly changing technology is one of the key factors enhancing the adoption and utilization of digital mammography devices. The technological advancements in hybrid imaging with mammography, such as CAD with mammography & X-ray imaging with mammography and growing product approval in this segment are some of the attributes that account for the largest market size.

However, breast tomosynthesis is yet to exhibit growth with an approximate CAGR of 13.4% in the coming few years. In the recent years, breast tomosynthesis has become the biggest technological development in mammography.

This technology was first launched in Europe in 2008 by Hologic, Inc. The product was approved for sales in 2011 in the U.S. market. The growing demand for technologically advanced techniques with improved cancer detection and diagnostic sensitivity is one of the key attributes representing the potential market growth over the forecast period.

North America held the majority of the share of about 42.8% in 2020. The region suffers from a burden of rising breast cancer cases and increasing women population of above 40 years.

North America has sophisticated healthcare facilities, and the reimbursement coverage contributes to the large share of the region. Moreover, increasing number of mammography units in the hospitals & diagnostic centers and number of units per million women population in the U.S. is also expected to drive the market.

Asia Pacific is projected to be the fastest growing market with a CAGR of 13.5% during the forecast period. The emerging economies, such as India and China, in the region are lucrative markets due to the dynamic change in the lifestyle of the urban part of the countries, which is leading to high prevalence of breast cancer. The local presence of significant players such as Hologic, Fujifilm, Philips Healthcare is one of the crucial factors further expected to boost the market in the coming years.

Key Players

Fujifilm; Hologic; Phillips Healthcare; Siemens Healthcare; Toshiba Medical Systems, Metaltronica; GE Healthcare; and I.M.S. Srl. Hologic

Market Segmentation

  • Product Outlook 
    • Film Screen Systems
    • Digital Systems
    • Analog Systems
    • Biopsy Systems
    • 3D Systems
  • Technology Outlook 
    • Breast Tomosynthesis
    • CAD
    • Digital
  • Regional Outlook 
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • MEA

Click Here to View Full Report Table of Contents

Full Report is Ready | Buy this Premium Research Report@

You can place an order or ask any questions, please feel free to contact at | +1 9197 992 333


Back to news